Zoetis

YTD

ALL

Trade Zoetis 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ZTS

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. It operates through the United States and International geographical segments.

CEO

Kristin C. Peck

CEOKristin C. Peck

Employees

14,500

Employees14,500

Headquarters

Parsippany, New Jersey

HeadquartersParsippany, New Jersey

Founded

1952

Founded1952

Employees

14,500

Employees14,500

ZTS Key Statistics

Market cap

31.13B

Market cap31.13B

Price-Earnings ratio

12.30

Price-Earnings ratio12.30

Dividend yield

2.78%

Dividend yield2.78%

Average volume

12.38M

Average volume12.38M

High today

$74.72

High today$74.72

Low today

$74.21

Low today$74.21

Open price

$75.93

Open price$75.93

Volume

27.11K

Volume27.11K

52 Week high

$172.23

52 Week high$172.23

52 Week low

$72.38

52 Week low$72.38

Stock Snapshot

Zoetis(ZTS) stock is priced at $74.48, giving the company a market capitalization of 31.13B. It carries a P/E multiple of 12.30 and pays a dividend yield of 2.8%.

On 2026-05-18, Zoetis(ZTS) stock traded between a low of $74.21 and a high of $74.72. Shares are currently priced at $74.48, which is +0.4% above the low and -0.3% below the high.

The Zoetis(ZTS)'s current trading volume is 27.11K, compared to an average daily volume of 12.38M.

During the past year, Zoetis(ZTS) stock moved between $72.38 at its lowest and $172.23 at its peak.

ZTS News

TipRanks 2h

Zoetis price target lowered to $112 from $145 at Citi

Citi lowered the firm’s price target on Zoetis (ZTS) to $112 from $145 and keeps a Buy rating on the shares. The firm cut the company’s estimates following the...

Simply Wall St 9h

Why Zoetis Is Down 10.4% After Trimming 2026 Outlook Amid Weaker Pet Demand - simplywall.st

...

Nasdaq 5d

S&P 500 Analyst Moves: ZTS

The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Zoetis is now the #5 analyst pick, mo...

Analyst ratings

64%

of 22 ratings

Buy

63.6%

Hold

36.4%

Sell

More ZTS News

Nasdaq 5d

Zoetis Achieves #133 Analyst Rank, Surpassing Republic Services

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Zoetis Inc (Symbol: ZTS) has taken over the #133 sp...

Simply Wall St 6d

Zoetis Valuation Check After Rare Q1 2026 Miss And Cut To Full Year Guidance

Zoetis (ZTS) is back in focus after its rare Q1 2026 miss on both revenue and earnings, a lowered full year outlook, and a sharp slide in the share price. The...

People also own

Based on the portfolios of people who own ZTS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.